bexmarilimab
faron pharmaceuticals
['matins', 'bexmarilimab', 'potentia', 'faron']
we ll be at 's annual meeting from today in orlando, florida, with 2 posters providing insights from our phi/ii matins trial of #bexmarilimab, our #immunotherapy candidate as a potential monotherapy in #metastatic or inoperable solid #tumors. hope to see you there! #aacr23 
Faron is a clinical stage biopharmaceutical company focused on harnessing the power of the immune system in order to tackle cancer and inflammation.